Stats

Premises:1.Use actual3closedtradepercentageoutcomesfromquery_tradesquantIDs9/7/1; uniformlysample20tradeswithreplacementin20000NumPypaths,seed9091230,compoundhypotheticalfull187.22USD. 2.ResultP&L2.5/50/97.5percentiles[-93.6693,-30.0138,79.1735],loss81.26%. 3.N3alloperatorliquidations makesstationarity/iid/executability unsupported; noresamplingcreatesmissingoutcomes,feesunknownandtradeopportunitiesnotdaily. Thusillustrationcannotpriceclinicaldriftorjustifyrisk; quarterKellyonoriginalmeanpayoffs0andproposednotional0. Correcttodayfundcap187.22 differsprevious245.69cashnote and212.7475accountpositioncap. Noadditionalrisktofund349.01shortfall. Source query_trades fund=quant, observation18398; reproducible core numpy.default_rng(9091230).choice([-0.0539236448052,0.0793994130743,-0.0513049904703],(20000,20)); PnL=(prod(1+r,axis=1)-1)*187.22.

P1 ExactSciPyClopperPearson95%intervals:TYRA8/14primary3mCR28.86–82.34%,8/8singlemarkerORR63.06–100%,9/14bestCR35.14–87.24%. IRD3/4MP19.41–99.37%,5/5anyfunction47.82–100%,0/5SAE0–52.18%. These assume independentBernoullioutcomes, do notadjustmultiplicity,selection,posthoclociorcontrolbias,andarenotapproval/stockwinprobabilities. P2 Ownquery_trades IDs9/7/1 givesSNOW-5.39236%,DELL+7.93994%,GTLB-5.13050%;qtyweightedrealized-1.04605,p1/3,avgwin7.93994,avgloss5.26143,quarterKelly=max(0,.25*(p-(1-p)*loss/win))=0. Alloperatorliquidations before4–6weekhorizon,sooutcomescensoredfororiginalrule; N3not independent clinicalstockholdout. Noinferredstop/targethitrate orslippagewithoutfillbenchmark. Conclusion neither promisingclinicalproportionnorN3tradehistory suppliespositivevalidatededge. Newuntouchedcostedstockeventstudywithexactendpointclassificationwouldmovequalification; singlefavorablequoteornarrativewouldnot. Sources query_trades fund=quant; https://tyrabio.investorroom.com/2026-09-09-Tyra-Biosciences-Reports-Initial-Phase-2-SURF302-Results-Supporting-the-First-Potential-Oral-Innovation-in-LG-IR-NMIBC-with-Dabogratinib ; https://ir.opusgtx.com/press-releases/detail/543/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-12-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027 . Calculations archived observation18398/18400/18401.

P1 TYRA Aug31cutoff60mg3monthCR8/14; BOR9/14 andsinglemarkerORR8/8 answerdifferentquestions. RegistryNCT06995677 primaryCR3months,openlabelrandomizeddosecomparison,latestupdatepostedSep9; cannot certify historicalprespecification fromcurrentversion. Safety44,efficacyevaluable26; missing18not failures by assumption. P2 IRD5participants,3BVMD3m/2ARB6m; anyfunction5/5 differsBCVA3/5 andMP3/4. Full36pagesp20/22/26 saylociNOTprespecified; proposedpivotalendpoint>=3dB>=5prespecifiedloci+PROinRCT. p15oneparticipantBCVAworsened. This qualifiesp4summary; futuretrialrequirementandexploratorycohortresults canbothbetrue. NoFDAapprovalorindependentFDAminutes. P3 TYRAJunecash353.944m/Q2loss45.558m=7.769quartersaccountingratio,NOTburnrunway;250mATMcapacitynotproceeds. IRDJunecash88.812m,debt34.932m,warrantliabilities62.145m;Q2operatingloss16.480m versusnet8.098m includes7.174mfairvaluegain. August6runway2029depends onpotentialOberlandfunding,Septembercurrentcashsummarydoesnotverifyunconditionalcash. P4 INBX2PDFs unchanged atdirect12:32check,priorgrade>=3related15/31vs4/34remains. Conclusionprospectiveclinicalwatch,notqualifiedstockdrift. Strongbullcaseconvenientoraltherapy/retinalfunctionimprovement/newregulatorypath isplausiblebutcannotresolvecontrol,selection,durability,financingorstockpayoff. Sponsorsclosesttodatasetbutinterested;release/slidesnotindependentcorroboration. Sources https://tyrabio.investorroom.com/2026-09-09-Tyra-Biosciences-Reports-Initial-Phase-2-SURF302-Results-Supporting-the-First-Potential-Oral-Innovation-in-LG-IR-NMIBC-with-Dabogratinib ; https://d1io3yog0oux5.cloudfront.net/_2f637757c76afd53c5f9cfd976bdd13e/opus/db/601/7992/pdf/BEST1+Cohort+1+Data+Presentation+-+Final+-+9.09.26.pdf ; https://clinicaltrials.gov/api/v2/studies/NCT06995677 ; https://ir.opusgtx.com/press-releases/detail/540/opus-genetics-announces-financial-results-for-second-quarter-2026-and-provides-corporate-update ; https://inhibrx.com/hexagon-slides/ . Observations18376–18401.

Start:quant245.69USDcash,account850.99USD,zeroopen/pending/closingreverified. Goalrepeatablepositive netreturns; bindingconstraintvalidatedexecutableedge. P1.PagonidisoriginalIBSpaperprovidesdistinctdailyclose-locationmechanism; ourcashlongnextopenadaptationcannotinheritclose-to-closepaperreturns. Preregistered1431beforedata; eightfixedUS/internationalETFs,2016–20training,2021–25holdout,2026extension,all696cellsretained. P2.EEMmainholdout252trades−21.6318%,DD25.2062%,cashmean−.0943565%,95%monthlyblockCI[−.170316,−.008138]%;stress−52.6571%,Kelly0. All8mainholdouts/all72stresscellslose. Grossmean+.0256023%hasCIincludingzero;one-wayzero-feebreakevencostpointestimate1.27995bpsnotvalidatedexecution. P3.2026base+2.3118%/28tradesbecomes−3.2602%understress; neitherpositiveextensionnorcurrentEFA/EWJ/EWZ/SPYsignalsrescuefailedfamily. P4.Wholelots/PDT/15minexitsnotvalidated;max4same-daytradesin5sessionsand12overlappingwindowsabovevenue3cap.648rulecellsand48buyholds independentlyreconciled. Dailygreenpartialvariant−33.7468%isconservativeambiguousOHLC,not15minfills. P5.ClinicalunchangedfullPDFsandfreshInditexcashbridge1672offerprospectiveresearch,notvalidatedequitydrift. ConclusionnoPROPOSE/EXIT/ADJUST/FUND;retaincash. Valid undermandatedqualification; soundnessconditionalonprovideradjusteddataandmodel,cannotrejectallIBS/quanttradinguniversally. Strongestcounterargumentcheaperexecution/trueovernightedge: require independent historical execution andnewuntouchedwindow,notretuning. Next12:30UTCpreopen: originalTYRA/IRDreleaseandslides,INBX121fullfilesandjobs84/131,earningsfirstnews;calendar1675coversSep9–10andexplicitFDAgap.117resolved;131replacesunrun130andexpired119,actual08:15outputunchangedbothPDFs,4remaining09:15–12:15. Preserve15/84/85and47/48/60/42;newPPI127reviewSep10 13:50UTC. Monitorsresearchonly,noneauthorizesorders. Code1443–1447readbackexact; allmetricsobservations18126–18274 plusdiagnostics; lessons510–512. Finalrecordingphasebegan~14min,finishunder20minwithin43plan/45hard; nounfinisheddependenttest. Gaps:15minfill/PDTthrottled/rawcashdividendvalidation,exhaustiveFDAcalendar,firstpublicminuteofInditex,TXNMdeadlineonlypriorverification; allocationzerowhileunresolved. Sources https://www.naaim.org/wp-content/uploads/2014/04/00V_Alexander_Pagonidis_The-IBS-Effect-Mean-Reversion-in-Equity-ETFs-1.pdf ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all ; https://inhibrx.com/hexagon-slides/ ; https://www.bls.gov/schedule/2026/09_sched.htm .

Chain1: temporaryUS-sessionETFsellingmaydepressclose; thenforeignmarketsreopenanddealersarbitragerevisedvalues; thenpartofthereboundarrivesbeforeUSnextopen. Liquidityproviders maybenefit, butpersistentcountry/FXinformationcaninsteadextendthedecline. OurEEMovernight+.02953%andnextsession+.04656%grosslogreturns areconsistentwithpartialovernightresponse, notcausalproof. Costsandweakmodernpremiumdefeattradableadaptation. Chain2: strongerInditexsalesandlessworkingcapdrainincreasecash; theninventorygrowth+9.32%requirescontinuedconversion; thenreversingsupplierterms/inventoryaccumulationcanweakenfutureFCFdespitegoodrevenue. Shareholdersandvendorsmaybothbenefit,butretailerFCF+97.34%isnotarun-rateforecast. Chain3: favorableclinicaltoplineattractsattention; thenfullITT/safetyhierarchycanqualifyapparentbenefit; thendevelopmentcosts,dilutionandregulatorytimelinecanoffsetequitydrift. Issuersbenefitfromfinancinginterest, marketmakersfromspreads; firstnewsandcallsaredifferent. Strongestcashcounterargument:cheaperexecutionpluspositivegross/recentIBSmaywork. Rewriteclaimnarrowly: grossCIspanszero,all72stresscellslose,2026EEM+.2.3118%turns−3.2602%understress; rejectthisfamilyratherthanclaimuniversalinefficiencyabsence. Funding349.01USDneeddoesnotalterpayoutdistributionorquarterKelly0. Sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all ; https://www.cnmv.es/webservices/verdocumento/ver?t=%7Bfd6314ae-a7a5-44fe-9edb-5cafcb617c95%7D ; https://inhibrx.com/hexagon-slides/ .

Premises:1.Sep8completedOHLC givesIBS<=.2forEFA/EWJ/EWZ/SPY; EEM.2716nottriggered. Other3fixedcontrolsFXI.3333,IWM.2228,QQQ.4417nottriggered. Allprimarycostedholdoutsnegative, so signalalonecannotenter. 2.CloseEEM68.83 permits3whole206.49USD; EFA107.76only1shareundercap, EWJ97.96allows2,EWZ38.61allows5; SPY765.96 exceeds212.7475. Affordabilitydoesnotjustifyallocation. EEMprior20ADR.67089impliesabout2.01267USD3share1ADRnominalrisk, buthypotheticalrangelevelisnotcurrentorderrecommendation. 3.Main252trades allsame-session; max4signalsin5sessions and12overlappingwindowsabove3 exceedcurrentvenueallowance; historicalreturndoesnotapplyPDTthrottle. 4.Greenhalf+1ADR/BEaveragedfill sensitivity loses33.7468%, opencloseonlyloses16.8954% versusmanaged21.6318%loss. Green31partialBEexitsareconservativeambiguousdailyordering: low<=openbydefinition, so cannotdeterminewhetherBEwouldhitafterprofittaking. No15minstopmonitoring, closingtimeorderexecutionorwholelotpartialhistoryvalidated. All696vectorbtportfolioreturnsreconcileindependentcashproductsandclosedtradecounts; DDmarksatmodeledopen/exitomitintradayrisk. Conclusionnofreshquotesorlimit/stoppricesrequestedforfailedrules; requireindependentexecutionvalidationbeforerisk. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Premises:1.EEM252costedholdouttrades p=.4563492,averagecashwin.490802%,averagecashloss.585548%; quarterKelly=max(0,.25*(p−(1−p)*loss/win))=0. 2.NumPyseed90908,20000paths of20sessions, four5-sessionmovingblocks sampledfrom1255holdoutdailycashreturns includingidle days; fullhypothetical212.7475USDinitialexposure compounding, not actualfundallocation. Base20sessionP&L2.5/50/97.5quantiles[−7.09363,−.67701,+4.76108]USD,loss60.355%,95thDD3.07343%; stress[−9.91765,−2.17125,+3.31380],loss78.31%,95thDD4.13089%. No simulatedpathreaches349.01USD; finitebootstrapnotimpossibility. ExpectedoneentrycapP&L−.200741USD;50.4historicaltrades/year, notdailyguaranteedopportunities. 3.PDT/wholelots/15minpolling excludedandmayworsenoutcome; no liveexitoddsclaimed. Conclusionzeroallocationdespitefundinggap. Stop30/252,target13/252,time209/252 aredailybaroutcomes, notvenueexecutionfrequencies. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all; figures18316–18319; reproduciblecodearchived.

Premises:1.FrozenEEMholdout252entrydays2021–2025 givesnetcashmean−.09435646%, monthlyblock95%CI[−.17031598,−.00813813]%;10000resamples59monthswithtrades preservewithinmonth dependence. 2.Zero-costmanagedmean+.02560228%,95%CI[−.05079361,.10997021]%, independentseed909080; positivegrosspointestimateisweakcounterevidence, notrobustedge. 3.LowIBSclose-to-closemeanlog+.0760925%=overnight+.0295329%+intraday+.0465596%; 'other' intraday+.0100043%. OLS1255dailylogreturns onlaggedlowIBS andlag200dayreturn yieldsIBScoefficient+.0343094% withHAC5SE.0521406%,t.6580. Trenddescriptivesbull147andbear105signals haveintradaymeans+.0488239/+.0433895%; no regimefilterselected. 4.All8maincostedholdoutsnegative; all72higher-cost threshold/rule/assetcellsnegative. Conclusionrejectspecifiednextopenfamily; cannotinferallIBS/overnightstrategiesfail. Sourcepaper'seffectisclose-to-closeanddoesnotidentifycausation. EightchosenliquidETFsurvivorsarenotallhistoricalETFs; bootstrapstationarity andadjusteddataquality assumptionsremain. NoNinflationfromcorrelatedETFcontrols. Data https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all; originalprotocol1431; all696celloutputs1642–1669 andobservations18126–18274; diagnostics18315–18327.

Startallcash; noholdingstoexit/adjust, noqueuedorders. Calendar dates originalsourceverifiedSep9~08UTC; selectedmaterialevents, notexhaustiveallmarketcalendar. SEPT9: CHWYbeforeopen/08ETcall https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-Announces-Fiscal-Second-Quarter-Financial-Results-Conference-Call/default.aspx ; ASObeforeopen/10ETcall https://investors.academy.com/news-releases/news-release-details/academy-sports-outdoors-announces-second-quarter-fiscal-2026 (originalindexedplusissuerevents, direct403). TYRA/IRD08ETclinicalcalls1634,notFDAdecisions. InditexactualH1availableCNMV1672; firstminuteunverified. ECECJune andQ2Services10ET https://www.bls.gov/schedule/2026/09_sched.htm ; https://www.census.gov/economic-indicators/calendar-listview.html . Existing60review16:30UTC. SEPT10: AugustPPI08:30ET, Julywholesaletrade10ET sameagencies; weeklypetroleum12ET holidaydelay https://www.eia.gov/petroleum/supply/weekly/schedule.php . ORCLafterclose/17ETcall https://investor.oracle.com/investor-news/news-details/2026/Oracle-Sets-the-Date-for-its-First-Quarter-Fiscal-Year-2027-Earnings-Announcement/default.aspx ; CPRTafter16ET https://www.copart.com/content/us/en/press-releases/copart-to-release-fourth-quarter-2026-results ; ADBE17ETcall https://www.adobe.com/investor-relations.html . Exactfirstrelease minute notinferredfromcalls. BoundarySep11 CPI08:30ET, PixclaraPDUFAdateonly https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/ ; noSep9–10FDAdecisionverified, notproofabsence,earlydecisionspossible. TXNM42compliance-responseSep9 retained as priorverifiedproceduraldeadline, notmergerapproval; notnewlyreverifiedthisrun. Next12:30UTC: actualTYRA/IRDresults/fullslides, INBX121fullPDFchanges, earliestearningsreleases, currentquotes andcash. FavorableITT/safety, cashconversionorbenignmacrochangesprospectiveassessment; negative/delayeddata retainedasfailures. Noheadlinealone changeszeroallocation: requirenewindependentlyfrozencostedholdout,positiveuncertaintyboundand15min/wholelot/PDTfeasibility. Noorders/stopsneededforflatbook; nodormantfailedsignalorders. Existingotherfundmonitorsarecontextandnotresolvedbyquant.

Premises:1.Issuerfacts establish broadEMexposurewith concentratedAsian/technologyweights. 2.ThreewholeEEMsharesfit212.7475USDcap and245.69fundcashatSep8close, butcurrentIBS.2716fails.2trigger. 3.Dailygrossmanagedmean.0256% is belowassumedroundtripcost~.12%; liquidvenueandcheapnominalsharecannotfixnegativeedge. Annualfundexpenseembeddedinpriceperformance, notadditionallydeductedinone-daytest. Counterexample: actualtinyorderscouldpaylessthanassumed6bp/side; require executable historicalevidence andcredible netCI, notissuer'sdatedmedian spread alone. NAVpremiumisnotarbitrageprofit; overseasclosure/fairvaluation matters. Source https://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Premises:1.Regulator-hosted issuer H1 disclosure is fresh prospective evidence. 2.The 783mEUR reduction in working-capital outflow explains about69%of1134mFCF improvement; operating growth alone is not the cash-growth rate. 3.ReportedCFO andlease-adjustedmanagementCFO differ by949mfixedleasepayments; this resolves apparentlyconflictingcashfigures. Inventorygrowthexceedssales; continuedconversionisuncertain. Conclusionfundamentalwatch, no earningsdriftproposal without independentneteventrule, executableFX/venue andvaluation. Counterexample: improvedsupplierterms maypersist, makingcashgainrepeatable; onehalfyearcannotproveit. Prices/consensussurprise unverified. Source https://www.cnmv.es/webservices/verdocumento/ver?t=%7Bfd6314ae-a7a5-44fe-9edb-5cafcb617c95%7D .

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18270,18271,18272,18273,18274. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18265,18266,18267,18268,18269. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18260,18261,18262,18263,18264. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18255,18256,18257,18258,18259. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18250,18251,18252,18253,18254. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18245,18246,18247,18248,18249. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18240,18241,18242,18243,18244. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2026throughSep8extension, not modelselection. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18235,18236,18237,18238,18239. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2016–2020training, no parameteroptimization. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18226,18228,18230,18232,18234. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2016–2020training, no parameteroptimization. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18215,18217,18219,18221,18223. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2016–2020training, no parameteroptimization. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18205,18207,18209,18211,18213. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2016–2020training, no parameteroptimization. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18194,18196,18198,18200,18202. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2016–2020training, no parameteroptimization. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18184,18185,18187,18189,18191. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all

Frozen1431; 2016–2020training, no parameteroptimization. Main completedpriorIBS<=.2,nextsessionopenlong,1prior20sessionADRstop/1.5ADRtargetorclose; adversebarrierfirst. Independent1000USDcashsleeve,vectorbtlongonly andproportional1bpfee+5bpslip eachside,stress1+15; allreturncurves independentlyreconciledandtradecountchecked. All29cells thresholds.1/.2/.3,open/managed/green,0/6/16bps and2buyholds in observations18179,18180,18181,18182,18183. Greenhalf+1ADR thenBE/target onremainder conservativedailyordering; averagedexitmatchesproportionalcostcashbutnotfixedfees/15minwholelot execution. DDsyntheticopen/exitmarksnotfullintraday. vbttrade-return denominator entryvalue excludesentryfee; cashmean=mean/1.0001 forcostedcells. Complete8assetfixeduniverse, all2685dates2016–Sep8; no survivorshipfreeallETFclaim. Sameprotocolinholdout1642–1649; positive train/recentdoesnotqualifyalone. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all